BioCentury
ARTICLE | Management Tracks

Actelion takeout, COVID-19 vaccine among Gorsky’s J&J highlights as he readies to hand CEO job to Duato 

Plus: BlueSphere, MAIA, Solid, Decibel, Corbus

August 20, 2021 1:50 AM UTC

Joaquin Duato will succeed Alex Gorsky as CEO of Johnson & Johnson (NYSE:JNJ), effective Jan. 3, capping a 10-year run for Gorsky as chairman and CEO that saw the company complete its ...



Access this Article